Last $5.29 USD
Change Today -0.14 / -2.58%
Volume 431.6K
XNPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeryl L. Hilleman M.B.A

Independent Director and Chairman of Audit Committee, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 3 different industries.

See Board Relationships
54$151,900

Background*

Ms. Jeryl L. Hilleman, MBA, served as Chief Financial Officer of Amyris, Inc., (formerly, Amyris Biotechnologies, Inc.) since January 2008 and serves as its Principal Accounting Officer. Ms. Hilleman also served as Advisor of Symyx Technologies Inc. until July 2010. She served as the Chief Financial Officer of Symyx Technologies Inc., from June 1997 to June 1, 2007 and as its Principal Accounting Officer, and Secretary. She served as Executive Vice President of Symyx ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

2005-Present
Independent Director and Chairman of Audit Committee

Education*

BA
Brown University
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$61,000
Total Calculated Compensation$151,900
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $5.29 USD -0.14

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
--
G. Kelly Martin Chief Executive Officer and Executive Director
Elan Corporation, plc
$2.1M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$567.0K
Peter Grant Chief Executive Officer, Chief Financial Officer, Finance Director and Executive Director
SkyePharma plc
528.0K GBP
Arun Sawhney B.Com., P.G.D.B.M.Managing Director, Chief Executive Officer, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee and Member of Science Committee
Ranbaxy Laboratories Ltd.
89.2M
Compensation as of Fiscal Year --.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.